DE STEFANO, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 36.694
EU - Europa 24.242
AS - Asia 15.432
SA - Sud America 2.987
AF - Africa 786
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 27
Totale 80.232
Nazione #
US - Stati Uniti d'America 36.320
GB - Regno Unito 6.378
CN - Cina 5.203
SG - Singapore 4.449
RU - Federazione Russa 4.401
IE - Irlanda 3.153
IT - Italia 2.519
BR - Brasile 2.464
UA - Ucraina 2.017
HK - Hong Kong 1.981
FR - Francia 1.516
VN - Vietnam 1.379
SE - Svezia 1.353
DE - Germania 1.226
KR - Corea 849
FI - Finlandia 729
IN - India 367
ZA - Sudafrica 340
NL - Olanda 207
AR - Argentina 185
ES - Italia 179
BD - Bangladesh 171
NG - Nigeria 169
CA - Canada 164
TR - Turchia 157
IQ - Iraq 154
MX - Messico 128
PK - Pakistan 96
AT - Austria 94
BE - Belgio 91
EC - Ecuador 87
JP - Giappone 82
PL - Polonia 76
ID - Indonesia 59
CO - Colombia 57
PH - Filippine 56
SA - Arabia Saudita 55
VE - Venezuela 55
CL - Cile 53
AU - Australia 52
KE - Kenya 49
MA - Marocco 49
UZ - Uzbekistan 44
CZ - Repubblica Ceca 36
DZ - Algeria 35
RO - Romania 35
CI - Costa d'Avorio 34
IR - Iran 34
PY - Paraguay 33
NP - Nepal 32
IL - Israele 31
AE - Emirati Arabi Uniti 30
EG - Egitto 29
TN - Tunisia 29
JO - Giordania 27
MK - Macedonia 25
AZ - Azerbaigian 24
CH - Svizzera 23
EU - Europa 23
KZ - Kazakistan 22
JM - Giamaica 20
PE - Perù 20
LT - Lituania 19
RS - Serbia 19
UY - Uruguay 19
MY - Malesia 18
GR - Grecia 17
BG - Bulgaria 16
MD - Moldavia 14
AL - Albania 13
DO - Repubblica Dominicana 13
SN - Senegal 13
HU - Ungheria 12
OM - Oman 12
SY - Repubblica araba siriana 12
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
PT - Portogallo 11
TH - Thailandia 11
BO - Bolivia 10
LB - Libano 10
KG - Kirghizistan 9
BY - Bielorussia 8
CG - Congo 8
DK - Danimarca 8
BH - Bahrain 7
CR - Costa Rica 7
ET - Etiopia 7
HN - Honduras 7
HR - Croazia 7
NO - Norvegia 7
PA - Panama 7
TT - Trinidad e Tobago 7
GE - Georgia 6
LU - Lussemburgo 6
AM - Armenia 5
BB - Barbados 5
BN - Brunei Darussalam 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
Totale 80.142
Città #
Southend 5.637
Dallas 4.619
Fairfield 4.003
Dublin 3.137
Houston 3.053
Ashburn 2.455
Singapore 2.380
Chandler 1.954
Woodbridge 1.917
Jacksonville 1.661
Wilmington 1.585
Seattle 1.576
Cambridge 1.390
Hong Kong 1.303
Menlo Park 1.283
Beijing 1.127
Moscow 1.088
Santa Clara 1.075
Hefei 1.057
Seoul 842
San Jose 770
Princeton 752
Ann Arbor 708
The Dalles 634
Nanjing 559
Siena 508
Ho Chi Minh City 420
Los Angeles 407
Council Bluffs 385
Lauterbourg 381
Hanoi 360
Milan 330
Helsinki 299
Johannesburg 296
Boardman 283
San Mateo 258
New York 224
São Paulo 221
San Diego 216
Buffalo 214
Nanchang 211
Columbus 171
Shenyang 162
Abuja 161
Munich 146
Florence 142
Málaga 117
Dong Ket 113
Norwalk 110
London 103
Tianjin 102
Orem 99
Rome 99
Bengaluru 96
Hebei 94
Changsha 91
Frankfurt am Main 86
Redondo Beach 83
Jiaxing 78
Lancaster 78
Düsseldorf 77
Kunming 77
Amsterdam 76
Shanghai 71
Brussels 68
Dearborn 68
Rio de Janeiro 68
San Francisco 65
Chennai 64
Chicago 62
Jinan 62
Falls Church 61
Tokyo 61
Warsaw 60
Belo Horizonte 59
Turku 59
Baghdad 57
Guangzhou 57
Vienna 57
Hangzhou 55
Lappeenranta 55
Toronto 55
Izmir 54
Brasília 53
Brooklyn 53
Nuremberg 52
Haiphong 51
Stockholm 50
Zhengzhou 50
Curitiba 49
Montreal 45
Da Nang 43
Phoenix 41
Boston 39
Mexico City 38
Ningbo 37
Tashkent 37
Denver 36
Abidjan 34
Biên Hòa 33
Totale 55.898
Nome #
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients 781
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. 588
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 472
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 462
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis 446
A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL 437
A new missense mutation in caveolin-3 gene causes rippling muscle disease. 394
A rare association of myasthenia gravis and mitochondrial myopathy: a clinical, biochemical and morphologic study of one case 366
A Rett syndrome MECP2 mutation that causes mental retardation in men 365
A new family with CADASIL: presentation of an homozygous patient and comparison with heterozigous phenotypes. 353
Hemodynamic evaluation of the optic nerve head in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 351
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment 342
1H-MR Spectroscopy in Traumatic Brain Injury 331
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 329
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 327
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects 325
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 303
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 302
A human post-mortem brain model for the standardization of multi-centre MRI studies 299
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 297
A novel approach with “skeletonised MTR” measures tract-specific microstructural changes in early primary-progressive MS 287
Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 287
A case of ovarioleukodystrophy without elF2B mutations 283
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 278
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 278
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 277
Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome 277
Diffuse brain damage in normal tension glaucoma 276
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 273
Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 271
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 270
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 269
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 265
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 260
Assessing response to interferon-β in a multicenter dataset of patients with MS 255
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 255
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 255
Toscana itaca (Italian CADASIL) registry: an implementable online database for CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). 252
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 252
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 251
Automated identification of brain new lesions in multiple sclerosis using subtraction images 251
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 250
Chemical pathology of acute demyelinating lesions and its correlation with disability 249
Blood–brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations 249
Genetic leukoencephalopaties with unknown metabolic pathogenesis 245
Serial KL-6 measurements in COVID-19 patients 245
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 244
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 244
CADASIL and cerebrovascular diseases 242
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 241
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 241
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 240
Brain atrophy assessment in multiple sclerosis: importance and limitations 239
Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study 239
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 239
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 239
Acute visual loss due to anterior ischemic optic neuropathy as first symptom in a patient with CADASIL 238
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 238
Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. 237
Altered Large-Scale Brain Functional Connectivity in Ocular Hypertension 237
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis 236
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 236
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 236
A practical review of the neuropathology and neuroimaging of multiple sclerosis 236
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 236
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders 236
Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system 234
Fingolimod effect on brain volume loss independently contributes to its effect on disability 234
Structural and functional brain changes beyond visual system in patients with advanced glaucoma 233
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 232
Cortical lesions in radiologically isolated syndrome. 231
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 229
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 229
Scoring treatment response in patients with relapsing multiple sclerosis 229
Optic atrophy in Marinesco-Sjögren syndrome: an additional ocular feature. Report of three cases in two families 228
Pathogenesis of multiple sclerosis: Insights from molecular and metabolic imaging 228
A multicentre study of motor functional connectivity changes in patients with multiple sclerosis 228
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 226
Early changes of brain connectivity in primary open angle glaucoma 226
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: A large-scale, multicentre study 225
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 224
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study 224
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 223
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 223
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 223
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis. 222
A Novel Mutation in the Notch3 Gene in an Italian Family with CADASIL: Genetic and MRI Spectroscopic Findings 222
Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease 220
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 220
Clinical Features and Outcome of the Guillain–Barre Syndrome: A Single-Center 11-Year Experience 219
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 218
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 217
Progression of regional grey matter atrophy in multiple sclerosis 217
Vitamin E deficiency secondary to chronic intestinal malabsorption and effect of vitamin supplement: a case report 216
Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency 213
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 209
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. 209
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 209
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 208
GABA: A new imaging biomarker of neurodegeneration in multiple sclerosis? 207
Totale 27.059
Categoria #
all - tutte 239.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.727 0 0 0 0 0 0 0 0 0 536 701 490
2021/20225.254 333 718 429 298 259 203 316 174 264 528 663 1.069
2022/20236.907 437 358 820 999 695 1.432 113 632 830 176 257 158
2023/20244.219 228 129 336 134 120 1.199 1.510 148 27 64 48 276
2024/202511.415 313 541 794 1.169 1.053 464 392 815 836 579 1.170 3.289
2025/202623.788 2.181 4.068 3.782 2.551 4.088 1.058 2.914 848 1.013 1.285 0 0
Totale 81.089